Reversing congestive heart failure with endothelin receptor antagonists.
Yazaki
Y
Y
Yamazaki
T
T
D000375:Aging / Q000378:metabolism; D000804:Angiotensin II / Q000502:physiology; D000818:Animals; D000077300:Bosentan; D002478:Cells, Cultured; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D011817:Rabbits; D017466:Receptors, Endothelin / Q000145:classification; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use
D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D017466:Receptors, Endothelin; D013449:Sulfonamides; D000804:Angiotensin II; D000077300:Bosentan